Clinical Trials Directory

Trials / Unknown

UnknownNCT02045992

Arrhythmic Effects of Hight Dose Caffeine

Effect of High-dose Caffeine on Cardiac Arrhythmias in Patients With Heart Failure - a Randomized Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
112 (estimated)
Sponsor
Luis Eduardo Paim Rohde · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Heart failure patients represent a group of individuals at higher risk for cardiac arrhythmias. There is a perception that caffeine consumption may represent an increase in this risk. Although the medical staff and health professionals suggest a reduction in the intake of this substance to patients considered at risk, there is no scientific proof for this recommendation. Some animal studies suggest a possible association between arrhythmias and caffeine use with higher doses, but this finding did not appear in human studies. In particular, little is known about the association between caffeine consumption and arrhythmias in patients with heart failure, especially at higher doses of consumption. More specific and safe guidelines on caffeine consumption are needed.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTcaffeineFive doses of 100mg of caffeine diluted in 100 ml of decaffeinated coffee. One dose every hour for five hours

Timeline

Start date
2013-04-01
Primary completion
2015-12-01
First posted
2014-01-27
Last updated
2014-09-25

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02045992. Inclusion in this directory is not an endorsement.